Dines Das in Kissimmee, Florida

Additional Medical Specialties Include:
CARDIOVASCULAR DISEASE (CARDIOLOGY), PULMONARY DISEASE

Medical School: Sorry, his university is not listed
Graduation Year: 1963
The Primary Medical Specialty for Dines Das is listed as: Internal Medicine
Approximate Years of Experience: 61
PAC (PECOS ID)#: 3678600038
NPI #: 1942281944
NPI Created On: 11/08/2005
NPI Last Updated Listed as: 11/23/2009
Primary Taxonomy Code: 207RC0000X
License Number:
19806
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Celtic Insurance Company
• Blue Cross Blue Shield
• Oscar Insurance Company of Florida
• Medicare

They are listed as accepting new patients in some locations.

Languages spoken by staff include: English, Indian, Indonesian.

---

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
4. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
5. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
6. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
7. Test for exercise-induced lung stress
8. Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen
9. New patient office or other outpatient visit, typically 60 minutes
10. Established patient office or other outpatient visit, typically 5 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Established patient office or other outpatient, visit typically 40 minutes
13. Technetium tc-99m sestamibi, diagnostic, per study dose
14. Injection, regadenoson, 0.1 mg
15. Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.